logo

4D Pharma Plc (LBPS)



Trade LBPS now with
  Date
  Headline
5/17/2022 4:45:39 AM 4D Pharma Reports Encouraging Results From Phase I/II Trial Of MRx-4DP0004 For Asthma
2/22/2022 7:13:14 AM 4D Pharma : FDA Clears IND Application For Live Biotherapeutics MRx0005 And MRx0029 For Parkinson's Disease Treatment
1/3/2022 7:05:41 AM 4D Pharma Appoints John Doyle As CFO
12/13/2021 7:16:31 AM 4D Pharma Announces Positive Topline Results From Part Of Phase I/II Trial Of MRx-4DP0004 For Treatment Of Asthma
7/26/2021 8:10:10 AM 4D Pharma CFO John Beck Passes Away